Association of thrombogenic genes polymorphisms with hepatocellular carcinoma in HCV Egyptian patients

Gene
Amr S HanafyRanda H Mohamed

Abstract

The rate of development of fibrosis varies among HCV patients and affected by many variables. We aimed to investigate the association between mutations in Factor V, prothrombin gene and thrombospondin 1 polymorphisms with hepatic fibrosis progression rate and development of HCC in patients infected with HCV and if they are potential markers for early prediction of disease progression. A total of 280 HCV-infected patients (70 with mild fibrosis, 70 with advanced fibrosis, 70 cirrhotic patients and 70 HCC patients) and 100 healthy controls were included. Factor V Leiden G1691A, prothrombin G20210A and thrombospondin 1 mutations were analyzed by restriction fragment length polymorphism. We observed that there were no significant differences between Factor V Leiden (G1691A) or TPS-1 (A2210G) polymorphisms in the four patient subgroups and control group. In HCC patients, the frequencies of GA genotype were significantly increased compared with control subject. HCV patients carrying GA genotype were more likely to develop hepatocellular carcinoma (OR=5.4, 95% CI=1.09-27.05; P=0.026).We concluded that the risk of HCC was increased 5-fold in subjects carrying GA genotype of prothrombin G20210A gene. However, there was no evidence for a...Continue Reading

References

Sep 1, 1981·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R G KnodellJ Wollman
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J H Hoofnagle
Dec 31, 1998·Gastroenterology·P ChamouardP Oudet
Feb 3, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L AmitranoA Balzano
Apr 20, 2001·The New England Journal of Medicine·U Seligsohn, A Lubetsky
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Patrick MarcellinNathalie Boyer
Feb 14, 2003·Gut·G V PapatheodoridisS J Hadziyannis
Jan 14, 2004·Journal of Thrombosis and Haemostasis : JTH·H CeelieH L Vos
Feb 10, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stefano FiorucciGiuseppe Cirino
May 8, 2004·American Heart Journal·Jennifer WesselJeanette J McCarthy
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ronnie T PoonSheung Tat Fan
Jul 21, 2004·Digestive Diseases and Sciences·Demetrios N SamonakisElias A Kouroumalis
Aug 4, 2004·Journal of Hepatology·Peter T Donaldson
Feb 18, 2005·European Journal of Gastroenterology & Hepatology·Ozlem ErkanOzden Uzunalimoglu
Feb 24, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Armando TripodiPier Mannuccio Mannucci
Apr 15, 2008·World Journal of Gastroenterology : WJG·Gulsum-Ozlem ElpekSevgi Bozova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.